BartonHaynesMD

Allergy & Immunology • Durham, NC

Professor, Medicine, Duke University School of Medicine

Join to view full profile

Dr. Haynes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haynes' full profile

Already have an account?

Office
2100 Erwin Rd
Durham, NC 27705
Phone+1 919-620-4467

Education & Training

Duke University HospitalResidency, Internal Medicine, 1973 - 1975
Baylor College of MedicineClass of 1973

Certifications & Licensure

NC State Medical License 1980 - 2025
TX State Medical License 1973 - 2012
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Clinical & Laboratory Immunology
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Elected Member Institute of Medicine, 1997
Elected Member The American Society for Clinical Investigation, 1983
Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Discovery and characterization of a pan-betacoronavirus S2-binding antibody.
Nicole V Johnson, Steven C Wall, Kevin J Kramer, Clinton M Holt, Sivakumar Periasamy
Structure. 2024-11-07
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies.
Rory Henderson, Kara Anasti, Kartik Manne, Victoria Stalls, Carrie Saunders
Nature Communications. 2024-11-03
1 citations
Influence of membrane on the antigen presentation of the HIV-1 envelope membrane proximal external region (MPER).
Cesar A López, S Munir Alam, Cynthia A Derdeyn, Barton F Haynes, Sandrasegaram Gnanakaran
Current Opinion in Structural Biology. 2024-10-01

Press Mentions

In a 1st, HIV Vaccine Triggers Rare and Elusive Antibodies in Human PatientsMay 21st, 2024
HIV Vaccine Triggered Elusive Broadly Neutralizing HIV Antibodies, Trial ShowsMay 20th, 2024
Developing New Tools to Fight CancerOctober 17th, 2022
Join now to see all